![Mark Parry-Billings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Parry-Billings
Presidente presso
SYNAIRGEN PLC
Profilo
Mark Parry-Billings is Executive Chairman at Synairgen Plc starting in 2025.
Former roles include Chief Executive Officer at Topigen Pharmaceuticals, Inc. from 2007 to 2010, Chairman at Zymenex A, Director at Innovata Biomed Ltd., Director at pSiMedica Ltd., Principal at Schering Health Care Ltd., and Head-Corporate Drug Development at CHIESI Farmaceutici SpA. Education includes a doctorate from the University of Oxford.
Posizioni attive di Mark Parry-Billings
| Società | Posizione | Inizio |
|---|---|---|
| SYNAIRGEN PLC | Presidente | 10/10/2024 |
Precedenti posizioni note di Mark Parry-Billings
| Società | Posizione | Fine |
|---|---|---|
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Amministratore Delegato | 01/01/2010 |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Corporate Officer/Principal | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Presidente | - |
Schering Health Care Ltd. | Corporate Officer/Principal | - |
Innovata Biomed Ltd.
 Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Direttore/Membro del Consiglio | - |
Formazione di Mark Parry-Billings
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
21
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Schering Health Care Ltd. | |
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Innovata Biomed Ltd.
Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Commercial Services |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops nanostructured porous silicon | Commercial Services |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
